Cargando…

The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden

INTRODUCTION: Long-term medication use is a recommended treatment for attention-deficit/hyperactivity disorder (ADHD), however, discontinuation is common. Non-medical factors which might influence initiation and discontinuation are understudied. Therefore, we investigated how different sociodemograp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gémes, Katalin, Taipale, Heidi, Björkenstam, Emma, Rahman, Syed, Gustafsson, Klas, Tanskanen, Antti, Ekselius, Lisa, Mittendorfer-Rutz, Ellenor, Helgesson, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165120/
https://www.ncbi.nlm.nih.gov/pubmed/37168083
http://dx.doi.org/10.3389/fpsyt.2023.1152286
_version_ 1785038202438942720
author Gémes, Katalin
Taipale, Heidi
Björkenstam, Emma
Rahman, Syed
Gustafsson, Klas
Tanskanen, Antti
Ekselius, Lisa
Mittendorfer-Rutz, Ellenor
Helgesson, Magnus
author_facet Gémes, Katalin
Taipale, Heidi
Björkenstam, Emma
Rahman, Syed
Gustafsson, Klas
Tanskanen, Antti
Ekselius, Lisa
Mittendorfer-Rutz, Ellenor
Helgesson, Magnus
author_sort Gémes, Katalin
collection PubMed
description INTRODUCTION: Long-term medication use is a recommended treatment for attention-deficit/hyperactivity disorder (ADHD), however, discontinuation is common. Non-medical factors which might influence initiation and discontinuation are understudied. Therefore, we investigated how different sociodemographic factors and comorbidities were associated with the initiation and discontinuation of ADHD medication use among young adults. METHODS AND RESULTS: We conducted a population-based prospective cohort study using individually linked administrative register data, in which we included all individuals residing in Sweden, between the age of 19 and 29 who were first diagnosed with ADHD between January 2006 and December 2016 (n = 59224). ADHD medication initiation was defined as the first prescription of ADHD medication in the period from 3 months before to 6 months after the cohort entry date. Those who initiated ADHD medication were followed up for medication use until discontinuation, death/emigration, or until 2019. Logistic and Cox regression models were used to investigate the associations between sociodemographics, health-related predictors and initiation, as well as discontinuation. Overall, 48.7% of the 41399 individuals initiated ADHD medication, most often methylphenidate (87%). Among the initiators, 15462 (77%) discontinued medication use during the follow-up (median time: 150 days). After mutually adjusting all other predictors, initiation was positively associated with older age, male sex, higher level of education, and negatively associated with living at home with parents, immigrant status, being unemployed during the year before inclusion, being on disability pension, having autism, substance use, schizophrenia-spectrum disorders, other mental disability/developmental disorders, cardiovascular diseases or previous accidents. Discontinuation was positively associated with being born abroad, living in big cities, being unemployed during the year before inclusion, having cancer, and negatively associated with a higher educational level, having depression, anxiety or stress-related disorder, autism spectrum disorder or diabetes. CONCLUSION: Besides medical factors, sociodemographics, such as educational attainment and immigrant status might also play a role in the initiation and discontinuation of ADHD medication use among young adults newly diagnosed with ADHD.
format Online
Article
Text
id pubmed-10165120
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101651202023-05-09 The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden Gémes, Katalin Taipale, Heidi Björkenstam, Emma Rahman, Syed Gustafsson, Klas Tanskanen, Antti Ekselius, Lisa Mittendorfer-Rutz, Ellenor Helgesson, Magnus Front Psychiatry Psychiatry INTRODUCTION: Long-term medication use is a recommended treatment for attention-deficit/hyperactivity disorder (ADHD), however, discontinuation is common. Non-medical factors which might influence initiation and discontinuation are understudied. Therefore, we investigated how different sociodemographic factors and comorbidities were associated with the initiation and discontinuation of ADHD medication use among young adults. METHODS AND RESULTS: We conducted a population-based prospective cohort study using individually linked administrative register data, in which we included all individuals residing in Sweden, between the age of 19 and 29 who were first diagnosed with ADHD between January 2006 and December 2016 (n = 59224). ADHD medication initiation was defined as the first prescription of ADHD medication in the period from 3 months before to 6 months after the cohort entry date. Those who initiated ADHD medication were followed up for medication use until discontinuation, death/emigration, or until 2019. Logistic and Cox regression models were used to investigate the associations between sociodemographics, health-related predictors and initiation, as well as discontinuation. Overall, 48.7% of the 41399 individuals initiated ADHD medication, most often methylphenidate (87%). Among the initiators, 15462 (77%) discontinued medication use during the follow-up (median time: 150 days). After mutually adjusting all other predictors, initiation was positively associated with older age, male sex, higher level of education, and negatively associated with living at home with parents, immigrant status, being unemployed during the year before inclusion, being on disability pension, having autism, substance use, schizophrenia-spectrum disorders, other mental disability/developmental disorders, cardiovascular diseases or previous accidents. Discontinuation was positively associated with being born abroad, living in big cities, being unemployed during the year before inclusion, having cancer, and negatively associated with a higher educational level, having depression, anxiety or stress-related disorder, autism spectrum disorder or diabetes. CONCLUSION: Besides medical factors, sociodemographics, such as educational attainment and immigrant status might also play a role in the initiation and discontinuation of ADHD medication use among young adults newly diagnosed with ADHD. Frontiers Media S.A. 2023-04-24 /pmc/articles/PMC10165120/ /pubmed/37168083 http://dx.doi.org/10.3389/fpsyt.2023.1152286 Text en Copyright © 2023 Gémes, Taipale, Björkenstam, Rahman, Gustafsson, Tanskanen, Ekselius, Mittendorfer-Rutz and Helgesson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Gémes, Katalin
Taipale, Heidi
Björkenstam, Emma
Rahman, Syed
Gustafsson, Klas
Tanskanen, Antti
Ekselius, Lisa
Mittendorfer-Rutz, Ellenor
Helgesson, Magnus
The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title_full The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title_fullStr The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title_full_unstemmed The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title_short The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
title_sort role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in sweden
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165120/
https://www.ncbi.nlm.nih.gov/pubmed/37168083
http://dx.doi.org/10.3389/fpsyt.2023.1152286
work_keys_str_mv AT gemeskatalin theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT taipaleheidi theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT bjorkenstamemma theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT rahmansyed theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT gustafssonklas theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT tanskanenantti theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT ekseliuslisa theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT mittendorferrutzellenor theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT helgessonmagnus theroleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT gemeskatalin roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT taipaleheidi roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT bjorkenstamemma roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT rahmansyed roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT gustafssonklas roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT tanskanenantti roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT ekseliuslisa roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT mittendorferrutzellenor roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden
AT helgessonmagnus roleofsociodemographicandclinicalfactorsintheinitiationanddiscontinuationofattentiondeficithyperactivitydisordermedicationamongyoungadultsinsweden